# NIH Reporter #2P50CA254838-06

The Memorial Sloan Kettering Cancer Center SPORE in Leukemia

**Recipient:** Sloan-Kettering Institute for Cancer Research

**Award Amount:** $3,031,373.00
**Ceiling:** $3,031,373.00

**Awarded:** September 17, 2026

**Identifier:** 2P50CA254838-06

The National Cancer Institute awarded support for the Memorial Sloan Kettering Cancer Center SPORE in Leukemia to develop and test therapies for acute myeloid leukemia, including targeted treatments and CAR T-cell approaches.

### Description

Funding supports research to develop targeted and immunotherapeutic approaches for acute myeloid leukemia, study treatment sensitivity and resistance, and improve patient outcomes. The program includes four research projects and shared resource and administrative cores.

[View original record](https://reporter.nih.gov/search/J7l2tQ4hHkqRePwGq3m5kA/project-details/11265367)